Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance
about
Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.Pseudomyxoma Peritonei as a First Manifestation of KRAS-Mutated Urachal Mucinous Cystadenocarcinoma of the Bladder: A Case Report.Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
P2860
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mutations of KRAS, NRAS, BRAF, ...... ce and prognostic significance
@en
Mutations of KRAS, NRAS, BRAF, ...... e and prognostic significance.
@nl
type
label
Mutations of KRAS, NRAS, BRAF, ...... ce and prognostic significance
@en
Mutations of KRAS, NRAS, BRAF, ...... e and prognostic significance.
@nl
prefLabel
Mutations of KRAS, NRAS, BRAF, ...... ce and prognostic significance
@en
Mutations of KRAS, NRAS, BRAF, ...... e and prognostic significance.
@nl
P2093
P2860
P356
P1433
P1476
Mutations of KRAS, NRAS, BRAF, ...... ce and prognostic significance
@en
P2093
Attila Szendröi
Benoit Peyronnet
Christian Niedworok
Herbert Rübben
Ilona Kovalszky
József Tímár
Kornélia Baghy
Krzysztof Okon
Marcell A Szász
Orsolya Módos
P2860
P304
39293-39301
P356
10.18632/ONCOTARGET.9828
P407
P50
P577
2016-06-01T00:00:00Z